Biotin-IETD-FMK is an enzyme inhibitor used for studying the function of cysteine-dependent proteases.
CAT No: HB00020
Biotin-IETD-FMK is a synthetic peptide-based inhibitor that features a biotinylated tetrapeptide sequence (Ile-Glu-Thr-Asp) conjugated to a fluoromethyl ketone (FMK) reactive group. As a cell-permeable, irreversible inhibitor, it is specifically designed to target and covalently modify active caspase-8 and related cysteine proteases. The presence of the biotin moiety enables sensitive detection and affinity purification, while the FMK group confers specificity and permanence in enzyme inhibition. Widely utilized in apoptosis research and protease profiling, Biotin-IETD-FMK serves as a valuable molecular probe for elucidating caspase-8 function, substrate specificity, and downstream signaling events in programmed cell death pathways.
Apoptosis research: Biotin-IETD-FMK is extensively employed in studies investigating the biochemical mechanisms underlying programmed cell death. By selectively inhibiting caspase-8, a key initiator caspase in the extrinsic apoptotic pathway, it allows researchers to dissect the sequence and regulation of proteolytic events during apoptosis. Its use helps clarify the role of caspase-8 in death receptor-mediated signaling, enabling the identification of upstream and downstream effectors and the mapping of complex apoptotic networks in diverse cellular models.
Protease activity profiling: The compound's biotin label provides a robust handle for affinity-based detection and enrichment of active caspase-8 and related proteases. In biochemical assays, it facilitates the capture of enzyme-inhibitor complexes from cell lysates via streptavidin-based pull-down techniques. This approach enables detailed profiling of caspase activation states, substrate engagement, and inhibitor selectivity, thereby supporting the characterization of protease dynamics in health and disease models.
Enzyme inhibitor validation: In inhibitor screening and specificity studies, Biotin-IETD-FMK acts as a benchmark tool for evaluating the potency and selectivity of novel caspase inhibitors. Its irreversible binding mechanism and well-characterized peptide sequence make it suitable for comparative analyses, helping to distinguish between competitive, reversible, and irreversible modes of inhibition. This application is critical for the rational design of new chemical probes and the assessment of off-target effects in drug discovery pipelines.
Affinity purification and target identification: The biotinylated structure of the inhibitor allows for the selective isolation of active caspase-8 and associated protein complexes from complex biological samples. When coupled with streptavidin-coated matrices, it enables the purification of covalently labeled enzymes, which can then be subjected to downstream analysis by mass spectrometry or immunoblotting. This strategy is instrumental in identifying interacting partners, post-translational modifications, and novel substrates of caspase-8, thereby expanding understanding of apoptotic signaling cascades.
Cell-based functional assays: In live-cell experiments, the cell-permeable nature of Biotin-IETD-FMK permits real-time inhibition of caspase-8 activity, allowing researchers to monitor the functional consequences of enzyme blockade in intact biological systems. Its application in time-course studies, dose-response experiments, and rescue assays provides valuable insights into the temporal dynamics of apoptosis, cellular stress responses, and protease-mediated signaling events. These functional assays are pivotal for deciphering the physiological relevance of caspase-8 in various cellular contexts and for validating mechanistic hypotheses in apoptosis research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.